Search


Renowned Pulmonary Disease Specialist to Lead UCSF Pulmonology Program News

Renowned Pulmonary Disease Specialist to Lead UCSF Pulmonology Program

Prescott Woodruff, MD, MPH, a renowned leader in the pathogenesis and treatment of airway disease, has been appointed chief of UC San Francisco’s Division of Pulmonary, Critical Care, Allergy and Sleep Medicine. Prescott will assume the role of chief on July 1.
New Research on Cell Regeneration Shows Promise for Treating Lung Injury and Fibrosis News

New Research on Cell Regeneration Shows Promise for Treating Lung Injury and Fibrosis

In a new study, UCSF researchers showed that they could successfully redirect profibrotic murine lung cells to a nonfibrotic state in which they regenerated alveoli. These findings could lead to novel treatments for lung injury and fibrosis.
UCSF Lung Transplant Patient No. 1,000 Looks Ahead to More of the Good Life News

UCSF Lung Transplant Patient No. 1,000 Looks Ahead to More of the Good Life

Hospital Innovations Boost 3-Year Survival From 50% in 2001 to 90% 20 Years Later
UCSF-led Study Uncovers Unique Stem Cell Trajectory in Lungs Damaged by COVID-19 and Pulmonary Fibrosis News

UCSF-led Study Uncovers Unique Stem Cell Trajectory in Lungs Damaged by COVID-19 and Pulmonary Fibrosis

In a collaborative study between UCSF researchers appearing December 30 in Nature Cell Biology, UCSF researchers Jaymin Kathiriya, PhD, and Chaoqun Wang, PhD, discovered that severe lung injuries can trigger lung stem cells to undergo abnormal differentiation. Drs. Kathiriya and Wang, supervised by Hal Chapman, MD, and Tien Peng, MD, respectively, utilized stem cell organoid models to uncover a novel stem cell pathway that is seen in severely injured lungs from COVID-19 and idiopathic pulmonary fibrosis patients.
Activating Immune Surveillance Mechanisms Shows Promise for Treating Diabetes and Pulmonary Fibrosis News

Activating Immune Surveillance Mechanisms Shows Promise for Treating Diabetes and Pulmonary Fibrosis

Researchers at UC San Francisco recently found that activating invariant natural killer T (iNKT) cells eliminated inflammatory senescent cells associated with chronic diseases in vivo. In the study, obese mice showed improved glucose control and mice with pulmonary fibrosis had decreased lung fibrosis and increased survival.
UCSF Post-COVID Clinic Treats Long Haulers News

UCSF Post-COVID Clinic Treats Long Haulers

UC San Francisco’s OPTIMAL Clinic (pOst-covid-19/PosT-Icu MultidisciplinAry cLinic) is one of the first clinics in the country established to provide follow-up care for patients who have recovered from COVID-19. The clinic’s goal is to optimize patient recovery through a centralized resource designed to coordinate with primary care services.
Lung Transplant Outcomes at UCSF Among the Nation’s Best News

Lung Transplant Outcomes at UCSF Among the Nation’s Best

For nine consecutive years, the UCSan FranciscoLung Transplant Program has achieved significantly higher-than-expected survival rates following transplant surgery. It is the only lung transplant program in the country with this record.
UCSF MD Link: Web-Based Communication Portal for Physicians Document

UCSF MD Link: Web-Based Communication Portal for Physicians

Our web portal allows referring physicians to securely access their patients’ entire electronic health record, make online referral requests and communicate with our physicians directly and securely.
Virtual Monitoring for Lung Transplant Patients Aided by Home Spirometry Device News

Virtual Monitoring for Lung Transplant Patients Aided by Home Spirometry Device

A new home spirometry kit combines a spirometer with a patient engagement platform to collect lung function data and symptoms remotely. This enables UCSF’s Lung Transplant team to remotely track patients with the goal of identifying both symptomatic and asymptomatic changes in lung function that may be the first sign of early chronic rejection.
Lung Transplant Program Document

Lung Transplant Program

For nine consecutive years, the UCSF Lung Transplant Program has had significantly higher-than-expected post-surgery survival rates — the only program in the country with this record.